Omega Healthcare Investors Reports 8-K Filing

TL;DR

OHI filed an 8-K on 9/30, reporting material agreements, obligations, and Reg FD disclosures.

AI Summary

Omega Healthcare Investors, Inc. filed an 8-K on October 1, 2025, reporting on events as of September 30, 2025. The filing indicates the entry into and termination of material definitive agreements, the creation of direct financial obligations, and includes Regulation FD disclosures and financial statements. Specific details regarding the nature of these agreements or obligations are not provided in this excerpt.

Why It Matters

This 8-K filing signals significant corporate actions by Omega Healthcare Investors, Inc., potentially impacting its financial obligations and agreements.

Risk Assessment

Risk Level: medium — The filing involves material definitive agreements and financial obligations, which can carry inherent risks depending on their specifics.

Key Players & Entities

• OMEGA HEALTHCARE INVESTORS, INC. (company) — Registrant
• September 30, 2025 (date) — Date of earliest event reported
• October 1, 2025 (date) — Filing date
• 303 International Circle, Suite 200 (location) — Principal business address
• Hunt Valley, Maryland 21030 (location) — Principal business address

FAQ

From the Filing

0000888491-25-000031.txt : 20251001 0000888491-25-000031.hdr.sgml : 20251001 20251001102349 ACCESSION NUMBER: 0000888491-25-000031 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20250930 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251001 DATE AS OF CHANGE: 20251001 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 251362934 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 8-K 1 ohi-20250930x8k.htm 8-K OMEGA HEALTHCARE INVESTORS, INC._September 30, 2025 0000888491 false 0000888491 2025-09-30 2025-09-30 ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K ​ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ​ Date of Report (Date of earliest event reported): September 30, 2025 ​ OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter) ​ Maryland 1-11316 38-3041398 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) ​ 303 International Circle, Suite 200 Hunt Valley , Maryland 21030 (Address of principal executive offices / Zip Code) ​ ( 410 ) 427-1700 (Registrant’s telephone number, including area code) ​ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐      Written communications pursuant to Rule 425 under the Securities Act. ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act. ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934: ​ Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.10 par value OHI New York Stock Exchange ​ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ​ Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ​ ​ Item 1.01 Entry into a Material Definitive Agreement. Omega Credit Agreement On September 30, 2025, Omega Healthcare Investors, Inc. (“ Omega ”) entered into a new senior unsecured $2.3 billion credit facility, comprised of a $2.0 billion multicurrency revolving credit facility (“ Revolving Credit Facility ”) and a $300.0 million delayed draw term loan facility (the “ DDTL Credit Facility &#8221